Alnylam Pharmaceuticals
ALNY
#603
Rank
S$52.85 B
Marketcap
S$396.11
Share price
0.70%
Change (1 day)
27.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company